
ORBIMED ADVISORS LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ARGX | 172K | $127.08M |
![]() | CI | 163K | $46.93M |
![]() | UTHR | 115K | $48.17M |
![]() | KRYS | 103K | $18.14M |
![]() | CELC | 84K | $4.15M |
![]() | XERS | 80K | $654.62K |
![]() | LYEL | 52K | $840.05K |
![]() | TMO | 47K | $22.55M |
![]() | KRRO | 32K | $1.55M |
![]() | INSM | 13K | $1.94M |

argenx SE
ARGX
Shares Held
172K
Value
$127.08M

Cigna Corporation
CI
Shares Held
163K
Value
$46.93M

United Therapeutics Corporation
UTHR
Shares Held
115K
Value
$48.17M

Krystal Biotech, Inc.
KRYS
Shares Held
103K
Value
$18.14M

Celcuity Inc.
CELC
Shares Held
84K
Value
$4.15M

Xeris Biopharma Holdings, Inc.
XERS
Shares Held
80K
Value
$654.62K

Lyell Immunopharma, Inc.
LYEL
Shares Held
52K
Value
$840.05K

Thermo Fisher Scientific Inc.
TMO
Shares Held
47K
Value
$22.55M

Korro Bio, Inc.
KRRO
Shares Held
32K
Value
$1.55M

Insmed Incorporated
INSM
Shares Held
13K
Value
$1.94M
